Danaher Corporation logo
Danaher Corporation (DHR)
Compare

Danaher Corporation (DHR) Operating Margin: 20.95%

Is Danaher Corporation’s operating margin high or low?

Danaher Corporation's operating margin of 20.95% is 10% below its 5-year average of 23.28%, near the low end of its 5-year range (19.35%–28.29%).

As of Wednesday, June 17, 2026. 1.69% below its 12-month average of 21.31%.

DHR Operating Margin Chart

DHR Operating Margin
20.91%-3.68% 1Y
Zoom

DHR Average Operating Margin Chart

DHR Current vs Average Operating Margin Chart

DHR Operating Margin Metrics

OPERATING MARGIN

20.95%

OPERATING MARGIN AVG TTM

21.31%

OPERATING MARGIN AVG 3Y

23.25%

OPERATING MARGIN AVG 5Y

23.28%

OPERATING MARGIN AVG 10Y

20.74%

OPERATING MARGIN AVG 15Y

18.54%

OPERATING MARGIN AVG 20Y

17.78%

CURRENT VS TTM AVG

-1.69%

CURRENT VS 3Y AVG

-9.90%

CURRENT VS 5Y AVG

-10.02%

CURRENT VS 10Y AVG

+1.03%

CURRENT VS 15Y AVG

+12.98%

CURRENT VS 20Y AVG

+17.84%

DHR Competitors' Operating Margin

NAMEMARKET CAPOPERATING MARGINTTM3Y5Y
Danaher Corporation (DHR)$128.06B20.95%21.31%23.25%23.28%
CVS Health Corporation (CVS)vs ›$127.73B1.46%2.43%2.79%3.48%
Stryker Corporation (SYK)vs ›$115.45B21.34%20.93%20.75%21.02%
Vertex Pharmaceuticals Incorporated (VRTX)vs ›$115.02B38.97%18.66%31.09%34.52%
Bristol-Myers Squibb Company (BMY)vs ›$114.19B25.67%23.17%21.31%19.39%
Intuitive Surgical, Inc. (ISRG)vs ›$145.70B30.45%28.70%26.89%27.25%
Pfizer Inc. (PFE)vs ›$148.41B23.45%25.29%24.23%24.05%
Medtronic plc (MDT)vs ›$103.29B17.78%17.77%17.25%17.00%
Abbott Laboratories (ABT)vs ›$157.84B18.17%17.21%17.41%17.71%
Gilead Sciences, Inc. (GILD)vs ›$158.06B38.26%22.76%25.11%25.54%

Operating Efficiency

Gross Margin

60.7%

Operating Margin

20.9%

Danaher Corporation Operating Margin Formula & Definition

Operating Margin = Operating Income / Revenue

Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Danaher Corporation Operating Margin FAQ

What is the operating margin for Danaher Corporation (DHR)?
The operating margin for DHR stock is 20.95%.
Is Danaher Corporation's operating margin high or low?
Danaher Corporation's operating margin of 20.95% is 10% below its 5-year average of 23.28%, near the low end of its 5-year range (19.35%–28.29%).
What is the TTM average operating margin for Danaher Corporation (DHR)?
The TTM average operating margin for DHR stock is 21.31%.
What is the 3Y average operating margin for Danaher Corporation (DHR)?
The 3Y average operating margin for DHR stock is 23.25%.
What is the 5Y average operating margin for Danaher Corporation (DHR)?
The 5Y average operating margin for DHR stock is 23.28%.
What is the 10Y average operating margin for Danaher Corporation (DHR)?
The 10Y average operating margin for DHR stock is 20.74%.
What is the 15Y average operating margin for Danaher Corporation (DHR)?
The 15Y average operating margin for DHR stock is 18.54%.
What is the 20Y average operating margin for Danaher Corporation (DHR)?
The 20Y average operating margin for DHR stock is 17.78%.

Danaher Corporation Operating Margin History

DATEOPERATING MARGIN
2025-12-3120.91%
2024-12-3121.71%
2023-12-3122.10%
2022-12-3128.29%
2021-12-3127.33%
2020-12-3119.35%
2019-12-3118.77%
2018-12-3118.01%
2017-12-3117.18%
2016-12-3117.69%
2015-12-3116.75%
2014-12-3118.09%
2013-12-3117.62%
2012-12-3117.50%
2011-12-3117.01%
2010-12-3116.92%
2009-12-3115.49%
2008-12-3115.37%
2007-12-3115.66%
2006-12-3115.69%
2005-12-3115.96%
2004-12-3115.92%
2003-12-3115.98%
2002-12-3115.32%
2001-12-3113.27%
2000-12-3114.62%
1999-12-3114.33%
1998-12-3112.60%
1997-12-3113.01%
1996-12-3112.48%

About Danaher Corporation

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Washington, DC
61,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Rainer Blair